| Literature DB >> 28856527 |
Maureen Hatch1, Mark P Little2, Alina V Brenner2, Elizabeth K Cahoon2, Valery Tereshchenko3, Ludmyla Chaikovska3, Igor Pasteur3, Ilya Likhtarov3, Andre Bouville2, Victor Shpak3, Olena Bolshova4, Galyna Zamotayeva4, Katherine Grantz5, Liping Sun5, Kiyohiko Mabuchi2, Paul Albert6, Mykola Tronko3.
Abstract
Iodine 131 (I-131), the principal component of nuclear fallout from the Chernobyl accident, concentrates in the thyroid gland and may pose risks to fetal development. To evaluate this, neonatal outcomes following the accident in April of 1986 were investigated in a cohort of 2582 in utero-exposed individuals from northern Ukraine for whom estimates of fetal thyroid I-131 dose were available. We carried out a retrospective review of cohort members' prenatal, delivery and newborn records. The relationships of dose with neonatal anthropometrics and gestational length were modeled via linear regression with adjustment for potentially confounding variables. We found similar, statistically significant dose-dependent reductions in both head circumference (-1.0 cm/Gy, P = 0.005) and chest circumference (-0.9 cm/Gy, P = 0.023), as well as a similar but non-significant reduction in neonatal length (-0.6 cm/Gy, P = 0.169). Gestational length was significantly increased with increasing fetal dose (0.5 wks/Gy, P = 0.007). There was no significant (P > 0.1) effect of fetal dose on birth weight. The observed associations of radioiodine exposure with decreased head and chest circumference are consistent with those observed in the Japanese in utero-exposed atomic bomb survivors.Entities:
Keywords: Chernobyl; In utero exposure; Iodine-131; Neonatal outcomes; Nuclear accident; Ukraine
Mesh:
Substances:
Year: 2017 PMID: 28856527 DOI: 10.1007/s10654-017-0299-y
Source DB: PubMed Journal: Eur J Epidemiol ISSN: 0393-2990 Impact factor: 8.082